Back
XTL Biopharmaceuticals Stock Price Chart
Sponsored
XTLB
Sponsored
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager
Sell
23
XTLB
XTL Biopharmaceuticals
Last Price:
2.42
Seasonality Move:
-2.49%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTLB is experiencing slight buying pressure.
XTL Biopharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.58 | Sell |
20-day SMA: | 2.65 | Sell |
50-day SMA: | 2.67 | Sell |
200-day SMA: | 1.98 | Buy |
8-day EMA: | 2.55 | Sell |
20-day EMA: | 2.62 | Sell |
50-day EMA: | 2.61 | Sell |
200-day EMA: | 2.14 | Buy |
XTL Biopharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 35.44 | Sell |
Chaikin Money Flow: | 1859 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
XTL Biopharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for XTL Biopharmaceuticals Stock
Is XTL Biopharmaceuticals Stock a Buy?
- XTL Biopharmaceuticals share price is 2.41 while XTLB 8-day simple moving average is 2.58, which is a Sell signal.
- The stock price of XTLB is 2.41 while XTL Biopharmaceuticals 20-day SMA is 2.65, which makes it a Sell.
- XTL Biopharmaceuticals 50-day simple moving average is 2.67 while XTLB share price is 2.41, making it a Sell technically.
- XTLB stock price is 2.41 and XTL Biopharmaceuticals 200-day simple moving average is 1.98, creating a Buy signal.
XTLB Technical Analysis vs Fundamental Analysis
Sell
23
XTL Biopharmaceuticals (XTLB)
is a Sell
Is XTL Biopharmaceuticals a Buy or a Sell?
-
XTL Biopharmaceuticals stock is rated a Sell
The current XTL Biopharmaceuticals [XTLB] share price is $2.41. The Score for XTLB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
XTL Biopharmaceuticals Stock Info
Market Cap:
13.13M
Price in USD:
2.41
Share Volume:
1.88K
XTL Biopharmaceuticals 52-Week Range
52-Week High:
4.99
52-Week Low:
0.75
Sell
23
XTL Biopharmaceuticals (XTLB)
is a Sell
XTL Biopharmaceuticals Share Price Forecast
-
What is the XTL Biopharmaceuticals stock price today?
The XTL Biopharmaceuticals stock price is 2.41 USD today. -
Will XTLB stock go up or go down?
XTL Biopharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is XTL Biopharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, XTL Biopharmaceuticals is overvalued.
Is XTL Biopharmaceuticals Stock a Buy?
- XTL Biopharmaceuticals share price is 2.41 while XTLB 8-day exponential moving average is 2.55, which is a Sell signal.
- The stock price of XTLB is 2.41 while XTL Biopharmaceuticals 20-day EMA is 2.62, which makes it a Sell.
- XTL Biopharmaceuticals 50-day exponential moving average is 2.61 while XTLB share price is 2.41, making it a Sell technically.
- XTLB stock price is 2.41 and XTL Biopharmaceuticals 200-day simple moving average is 2.14, creating a Buy signal.
Technical Analysis of XTL Biopharmaceuticals
Should I short XTL Biopharmaceuticals stock?
- XTLB Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting XTL Biopharmaceuticals is a Sell
- XTL Biopharmaceuticals Relative Strength Index (RSI) is 35.44, which suggest XTL Biopharmaceuticals is oversold
- The Bollinger Bands (25) for XTL Biopharmaceuticals is ( - ), which suggest XTL Biopharmaceuticals is a Buy
- The Bollinger Bands (100) for XTL Biopharmaceuticals is ( - ), which suggest XTL Biopharmaceuticals is a Buy
* XTL Biopharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.